Table 3.
Hospitalisation outcomes for patients with the delta variant compared with patients with the alpha variant, by vaccination status
Alpha variant* | Delta variant* | Adjusted HR (95% CI)†, delta variant vs alpha variant | p value‡ | |
---|---|---|---|---|
Hospital admission | ||||
Unvaccinated or <21 days after first vaccination dose | 536/28 029 (1·9%) | 149/6681 (2·2%) | 2·32 (1·29–4·16) | .. |
≥21 days after first vaccination dose with or without second vaccination dose | 228/6627 (3·4%) | 47/2001 (2·3%) | 1·94 (0·47–8·05) | 0·82 |
Hospital admission or emergency care attendance | ||||
Unvaccinated or <21 days after first vaccination dose | 1095/28 029 (3·9%) | 369/6681 (5·5%) | 1·43 (1·04–1·97) | .. |
≥21 days after first vaccination dose with or without second vaccination dose | 353/6627 (5·3%) | 129/2001 (6·4%) | 1·58 (0·69–3·61) | 0·82 |
Data are n/N (%) except where otherwise stated. HR=hazard ratio.
These crude descriptive frequencies are unadjusted for age and other confounders, and so they are not directly comparable between the groups.
Stratification for age group, ethnicity, lower-tier local authority, calendar week, vaccination status; regression adjustment for age, sex, index of multiple deprivation, specimen date, and international travel status.
p values are for tests for interaction between vaccination status and variant.